Skip to main content
Premium Trial:

Request an Annual Quote

Todd Johnson, Risa Lavizzo-Mourey, John Berriman

MDS Pharma Services has appointed Todd Johnson to be senior vice president of strategy and corporate development.
 
Johnson previously was a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company. He also was CEO of Tangerine Technologies and was a cancer researcher at Harvard’s Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health
 

 
Beckman Coulter said this week that Risa Lavizzo-Mourey has resigned from the company’s board of directors, effective June 1. She is currently president and CEO of the Robert Wood Johnson Foundation. Beckman said it is conducting a search for candidates to replace Lavizzo-Mourey.
 

 
Belgian biomarker company Pronota has appointed John Berriman chairman. Berriman was chairman of Algeta and is a director at MicroMet, Ablynx, and Oxxon Therapeutics.
 
He had been a director at Abingworth Management, worked at Celltech Group and Celltech Therapeutics, and founded Celltech Biologics. Berriman also was a director and co-founder at Solexa, chairman of Chroma Therapeutics, and was a director at Epigenomics, Alnylam, and XCounter.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.